Overview
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 24, 2026 | PGxAI Announces Andromeda Precision Prescribing Platform Is Qualified on Mayo Clinic Platform | What You Should Know PGxAI, an AI-native precision medicine company specializing in personalized prescribing and human drug-metabolism intelligence, announced that its Andromeda clinical decision-support platform is now a Qualified Solution... |
| Aug 24, 2026 | PGxAI Announces Andromeda Is Now a Qualified Solution on Leading Healthcare Platform | PGxAI Participation in Solutions Studio creates a structured route to integration in care delivery environments and access to Mayo Clinic Platform’s provider network. PALO ALTO, CA, UNITED STATES, August 24, 2026 /EINPresswire.com/ -- PGxAI... |
| Dec 9, 2025 | PGxAI and Lean Business Services Partner to Scale AI Pharmacogenomics in Saudi Arabia | What You Should Know: – PGxAI has entered a strategic partnership with Lean Business Services and Najashi Holding to deploy AI-driven pharmacogenomics across Saudi Arabia, supporting the Kingdom’s Vision 2030 Health Sector Transformation Pr... |
| Apr 15, 2025 | PGxAI Launches Deneb: AI Model Revolutionizing Drug Development with Pharmacogenetics | What You Should Know: – PGxAI, a pioneering leader in the field of AI-driven pharmacogenetics, today announced the launch of Deneb, its latest cutting-edge model poised to transform the landscape of drug development. – Deneb is specifically... |
| PGxAI | “PGxAI Artificial Intelligence for Pharmacogenetics and Personalized Medicine” |
Reviews 0
FAQ about PGxAI
What has the press written about PGxAI?
Parsers VC has collected 6 articles mentioning PGxAI, among them “PGxAI Announces Andromeda Precision Prescribing Platform Is Qualified on Mayo Clinic Platform” (Aug 24, 2026) and “PGxAI Announces Andromeda Is Now a Qualified Solution on Leading Healthcare Platform” (Aug 24, 2026).
Is PGxAI still active?
Yes, PGxAI is active; its latest activity on Parsers VC dates from Sep 14, 2026.